Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Direct-to-consumer Genetic Testing Market by Type (Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing, Direct-to-consumer Genetic Testin), By Application (Online, Offline) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Direct-to-consumer Genetic Testing Market by Type (Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing, Direct-to-consumer Genetic Testin), By Application (Online, Offline) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168398 3300 Medical Devices & Consumables 377 238 Pages 4.8 (43)
                                          

The global directconsumer genetic testing market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing awareness about genetic disorders and diseases among people, which in turn leads to an increase in demand for directconsumer genetic tests. Moreover, the increasing number of research and development activities in this field are also driving the growth of this market. The global directconsumer genetic testing market can be segmented on the basis of type into diagnostic screening, prenatal, newborn screening, and preimplantation diagnosis; on the basis of application into online and offline; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). The diagnostic screening segment accounted for a major share in 2018 owing to its wide range applications such as cancer detection or diagnosis for hereditary diseases such as cystic fibrosis or Huntington’s disease. The prenatal segment is expected to grow at a higher CAGR during 2020-2030 owing to its wide range applications such as detecting Down syndrome or other chromosomal abnormalities before birth.

Some Of The Growth Factors Of This Market:

  1. The market for direct-to-consumer genetic testing is growing due to the increased availability of affordable genetic testing kits and the increased awareness of the benefits of genetic testing.
  2. The market for direct-to-consumer genetic testing is expected to grow as more people are becoming aware of their risk factors and want to take control over their health by knowing what they are at risk for.
  3. Direct-to-consumer genetic tests can be used in a variety of ways, such as determining if someone has a gene that makes them more susceptible to certain diseases or conditions, determining if someone is at risk for passing on a hereditary disease or condition, and determining if someone has an increased chance of developing certain diseases or conditions in the future.
  4. Direct-to-consumer genetics tests can be used by doctors to help diagnose patients with rare disorders that may not have been previously diagnosed because they were not looking for it specifically, but rather just looking at all possible causes based on symptoms presented by the patient.
  5. Genetic information can also be used by doctors when deciding which treatments would work best with each individual's DNA.

Industry Growth Insights published a new data on “Direct-to-consumer Genetic Testing Market”. The research report is titled “Direct-to-consumer Genetic Testing Market research by Types (Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing, Direct-to-consumer Genetic Testin), By Applications (Online, Offline), By Players/Companies 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes, Direct-to-consumer Genetic Testin”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Direct-to-consumer Genetic Testing Market Research Report

By Type

Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing, Direct-to-consumer Genetic Testin

By Application

Online, Offline

By Companies

23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes, Direct-to-consumer Genetic Testin

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

238

Number of Tables & Figures

167

Customization Available

Yes, the report can be customized as per your need.


Global Direct-to-consumer Genetic Testing Industry Outlook


Global Direct-to-consumer Genetic Testing Market Report Segments:

The global Direct-to-consumer Genetic Testing market is segmented on the basis of:

Types

Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing, Direct-to-consumer Genetic Testin

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Online, Offline

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. 23andMe
  2. MyHeritage
  3. LabCorp
  4. Myriad Genetics
  5. Ancestry.com
  6. Quest Diagnostics
  7. Gene By Gene
  8. DNA Diagnostics Center
  9. Invitae
  10. IntelliGenetics
  11. Ambry Genetics
  12. Living DNA
  13. EasyDNA
  14. Pathway Genomics
  15. Centrillion Technology
  16. Xcode
  17. Color Genomics
  18. Anglia DNA Services
  19. African Ancestry
  20. Canadian DNA Services
  21. DNA Family Check
  22. Alpha Biolaboratories
  23. Test Me DNA
  24. 23 Mofang
  25. Genetic Health
  26. DNA Services of America
  27. Shuwen Health Sciences
  28. Mapmygenome
  29. Full Genomes
  30. Direct-to-consumer Genetic Testin

Global Direct-to-consumer Genetic Testing Market Overview


Highlights of The Direct-to-consumer Genetic Testing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Diagnostic Screening
    2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
    3. Relationship Testing
    4. Direct-to-consumer Genetic Testin
  1. By Application:

    1. Online
    2. Offline
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Direct-to-consumer Genetic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Direct-to-consumer Genetic Testing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Direct-to-consumer genetic testing is a process by which individuals can order tests that assess their personal risk for certain diseases or conditions. These tests are typically offered through online platforms and may be marketed to consumers as a way to better understand their health and potential risks. While direct-to-consumer genetic testing has the potential to provide valuable information about an individual's health, it is also possible for these tests to be inaccurate or misleading.

Some of the key players operating in the direct-to-consumer genetic testing market are 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes, Direct-to-consumer Genetic Testin.

The direct-to-consumer genetic testing market is expected to register a CAGR of 12.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Direct-to-consumer Genetic Testing Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Direct-to-consumer Genetic Testing Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Direct-to-consumer Genetic Testing Market - Supply Chain
   4.5. Global Direct-to-consumer Genetic Testing Market Forecast
      4.5.1. Direct-to-consumer Genetic Testing Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Direct-to-consumer Genetic Testing Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Direct-to-consumer Genetic Testing Market Absolute $ Opportunity

5. Global Direct-to-consumer Genetic Testing Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
      5.3.1. Diagnostic Screening
      5.3.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
      5.3.3. Relationship Testing
      5.3.4. Direct-to-consumer Genetic Testin
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Direct-to-consumer Genetic Testing Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
      6.3.1. Online
      6.3.2. Offline
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Direct-to-consumer Genetic Testing Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Direct-to-consumer Genetic Testing Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Direct-to-consumer Genetic Testing Demand Share Forecast, 2019-2026

9. North America Direct-to-consumer Genetic Testing Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
      9.4.1. Online
      9.4.2. Offline
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
      9.7.1. Diagnostic Screening
      9.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
      9.7.3. Relationship Testing
      9.7.4. Direct-to-consumer Genetic Testin
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Direct-to-consumer Genetic Testing Demand Share Forecast, 2019-2026

10. Latin America Direct-to-consumer Genetic Testing Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
      10.4.1. Online
      10.4.2. Offline
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
      10.7.1. Diagnostic Screening
      10.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
      10.7.3. Relationship Testing
      10.7.4. Direct-to-consumer Genetic Testin
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Direct-to-consumer Genetic Testing Demand Share Forecast, 2019-2026

11. Europe Direct-to-consumer Genetic Testing Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
      11.4.1. Online
      11.4.2. Offline
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
      11.7.1. Diagnostic Screening
      11.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
      11.7.3. Relationship Testing
      11.7.4. Direct-to-consumer Genetic Testin
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Direct-to-consumer Genetic Testing Demand Share, 2019-2026

12. Asia Pacific Direct-to-consumer Genetic Testing Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
      12.4.1. Online
      12.4.2. Offline
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
      12.7.1. Diagnostic Screening
      12.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
      12.7.3. Relationship Testing
      12.7.4. Direct-to-consumer Genetic Testin
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Direct-to-consumer Genetic Testing Demand Share, 2019-2026

13. Middle East & Africa Direct-to-consumer Genetic Testing Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
      13.4.1. Online
      13.4.2. Offline
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
      13.7.1. Diagnostic Screening
      13.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
      13.7.3. Relationship Testing
      13.7.4. Direct-to-consumer Genetic Testin
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Direct-to-consumer Genetic Testing Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Direct-to-consumer Genetic Testing Market: Market Share Analysis
   14.2. Direct-to-consumer Genetic Testing Distributors and Customers
   14.3. Direct-to-consumer Genetic Testing Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. 23andMe
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. MyHeritage
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. LabCorp
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Myriad Genetics
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Ancestry.com
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Quest Diagnostics
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Gene By Gene
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. DNA Diagnostics Center
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Invitae
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. IntelliGenetics
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Ambry Genetics
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Living DNA
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. EasyDNA
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Pathway Genomics
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Centrillion Technology
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Xcode
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. Color Genomics
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. Anglia DNA Services
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. African Ancestry
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. Canadian DNA Services
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us